Enhancement of the T140-based pharmacophores leads to the development of more potent and bio-stable CXCR4 antagonists.
暂无分享,去创建一个
M. Akamatsu | J. Trent | A. Otaka | H. Tamamura | N. Fujii | H. Nakashima | S. Peiper | N. Yamamoto | K. Hiramatsu | S. Ueda | S. Kusano | S. Terakubo | Zixuan Wang | Makiko Mizumoto